Skip to main content
Paul Meyer, MD, Pathology, Tucson, AZ

Paul N Meyer MD

Hematopathology, Anatomic Pathology, Clinical Pathology


Pathologist at MYERS DAVID PAUL DO PC

Join to View Full Profile
  • 3601 S 6th AveTucson, AZ 85723

  • Phone+1 520-629-4629

  • Fax+1 520-629-1756

Are you Dr. Meyer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Paul Meyer, MD is a board certified pathologist in Tucson, Arizona. He is currently licensed to practice medicine in Arizona, Iowa, and California.

Education & Training

  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineFellowship, Hematopathology, 2008 - 2010
  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 2004

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2012 - Present
  • CA State Medical License
    CA State Medical License 2011 - Present
  • NE State Medical License
    NE State Medical License 2007 - 2026
  • IA State Medical License
    IA State Medical License 2025 - 2025
  • MT State Medical License
    MT State Medical License 2011 - 2013
  • NV State Medical License
    NV State Medical License 2011 - 2013
  • ID State Medical License
    ID State Medical License 2010 - 2012
  • Pathology - Anatomic/Pathology - Clinical
    American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • Hematopathology
    American Board of Pathology Hematopathology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Sirolimus (Rapamycin) for the Targeted Treatment of the Fibrotic Sequelae of Graves’ Orbitopathy
    Sirolimus (Rapamycin) for the Targeted Treatment of the Fibrotic Sequelae of Graves’ OrbitopathyFebruary 14th, 2019